Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Linda Henry

Showing results (221-230 of 280) with videos related to

Pageof 28
Sort By:
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 22, 2018
Changes in Renal Function in Patients With Chronic HBV Infection Treated With Tenofovir Disoproxil Fumarate vs EntecavirSam Trinh, An K Le, Ellen T Chang, et al.
Alimentary Pharmacology & Therapeutics|February 27, 2025
Differential Characteristics and Survival Outcomes of Patients With Cirrhosis According to Underlying Liver AetiologyYu Shi, Nicholas Chien, Ashley Fong, et al.
Saudi Journal of Gastroenterology : Official Journal of the Saudi Gastroenterology Association|July 1, 2024
The burden of metabolic dysfunction-associated steatotic liver disease and viral hepatitis in Saudi ArabiaSaleh A Alqahtani, Faisal Abaalkhail, Saad Alghamdi, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 23, 2017
Hepatitis C in Patients With Minimal or No Hepatic Fibrosis: The Impact of Treatment and Sustained Virologic Response on Patient-Reported OutcomesZobair M Younossi, Maria Stepanova, Tarik Asselah, et al.
Medcomm|April 8, 2026
Differential Mortality Risk by Age in Males and Females With Steatotic Liver DiseaseTaotao Yan, Nicholas Chien, Vy H Nguyen, et al.
JHEP Reports : Innovation in Hepatology|February 18, 2026
Longitudinal risk of cirrhosis by steatotic liver disease subtype among 1.5 million individuals in the USMai Sedki, Zeyuan Yang, Ashwani K Singal, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 28, 2025
"Weekend Warrior" Exercise Pattern Protects Against MASLD and Mortality Comparable to Regular Exercise: National Cohort StudyShira Zelber-Sagi, James M Paik, Dana Ivancovsky-Wajcmen, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 13, 2026
Twenty-Year Trends in Liver Transplantation Among Hepatitis D Virus-Infected Patients in the U.S. and EuropeZobair M Younossi, Giacomo Germani, Maria Buti, et al.
Plos One|February 25, 2022
Outcomes of hospitalized patients with COVID-19 during the course of the pandemic in a fully integrated health systemBrian Lam, Maria Stepanova, Chapy Venkatesan, et al.
JAMA Network Open|November 18, 2024
Trends in Hepatocellular Carcinoma Mortality Rates in the US and Projections Through 2040Sikai Qiu, Jiangying Cai, Zhanpeng Yang, et al.
Pageof 28

Showing results (221-230 of 280) with videos related to

Sort By:
Pageof 28
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 22, 2018
Changes in Renal Function in Patients With Chronic HBV Infection Treated With Tenofovir Disoproxil Fumarate vs EntecavirSam Trinh, An K Le, Ellen T Chang, et al.
Alimentary Pharmacology & Therapeutics|February 27, 2025
Differential Characteristics and Survival Outcomes of Patients With Cirrhosis According to Underlying Liver AetiologyYu Shi, Nicholas Chien, Ashley Fong, et al.
Saudi Journal of Gastroenterology : Official Journal of the Saudi Gastroenterology Association|July 1, 2024
The burden of metabolic dysfunction-associated steatotic liver disease and viral hepatitis in Saudi ArabiaSaleh A Alqahtani, Faisal Abaalkhail, Saad Alghamdi, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 23, 2017
Hepatitis C in Patients With Minimal or No Hepatic Fibrosis: The Impact of Treatment and Sustained Virologic Response on Patient-Reported OutcomesZobair M Younossi, Maria Stepanova, Tarik Asselah, et al.
Medcomm|April 8, 2026
Differential Mortality Risk by Age in Males and Females With Steatotic Liver DiseaseTaotao Yan, Nicholas Chien, Vy H Nguyen, et al.
JHEP Reports : Innovation in Hepatology|February 18, 2026
Longitudinal risk of cirrhosis by steatotic liver disease subtype among 1.5 million individuals in the USMai Sedki, Zeyuan Yang, Ashwani K Singal, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 28, 2025
"Weekend Warrior" Exercise Pattern Protects Against MASLD and Mortality Comparable to Regular Exercise: National Cohort StudyShira Zelber-Sagi, James M Paik, Dana Ivancovsky-Wajcmen, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 13, 2026
Twenty-Year Trends in Liver Transplantation Among Hepatitis D Virus-Infected Patients in the U.S. and EuropeZobair M Younossi, Giacomo Germani, Maria Buti, et al.
Plos One|February 25, 2022
Outcomes of hospitalized patients with COVID-19 during the course of the pandemic in a fully integrated health systemBrian Lam, Maria Stepanova, Chapy Venkatesan, et al.
JAMA Network Open|November 18, 2024
Trends in Hepatocellular Carcinoma Mortality Rates in the US and Projections Through 2040Sikai Qiu, Jiangying Cai, Zhanpeng Yang, et al.
Pageof 28